Posts filed under ‘Spinoff’
BDR Technologies well received by US investors, now on to Banff!
BDR Technologies r
was well received at the Modern Engergy Forum this week in Denver . BDR Techologies was recognized with first prize in the Rising Star Company presentations at the Modern Energy Investment Forum. This week BDR also presented at the Rice Alliance Energy and Clean Technology Venture Forum in Houston.
BDR Technologies is a uOttawa spin-off company built around bio-diesel reactor technology and intellectual property arising from Drs. Andre Tremblay and Marc Dube from the Faculty of Engineering. BDR Technoloigies and the original research have been supported by several government programs and by OTTN.
BDR will next be featured at the Banff Venture Forum, Canada’s premier company financing event Oct. 6 & 7th
BDR was featured in the news release issued by the Canadian Consulate General – Denver earlier this week.
Media Contact:
Jennifer Cook
Consulate General of Canada in Denver
Communications & Cultural Affairs Officer
303.626.0672 (phone) or 303.589.8782 (mobile)
jennifer.cook@international.gc.ca
For Immediate Release:
Sept. 13 – 15: Canadian Consulate Hosts Top-Tier Renewable Energy Companies during Colorado’s Modern Energy Investors Forum at The Ritz Carlton, Denver
DENVER—September 13, 2011—Investors, financial analysts and business leaders from the U.S. Rocky Mountain Region will have the opportunity to learn more about Canadian start-up companies specializing in innovative and cost-competitive renewable energy, clean technologies and sustainability services during the 2011 Modern Energy Investor Forum. The Forum takes place in Denver this week at The Ritz Carlton from Tuesday, Sept. 13, to Thursday, Sept. 15.
The Forum gathers top experts in the industry and brings them to Denver for discussions on ongoing development of technology transfer, market incentives, development projections and investment opportunities. Company representatives from start-ups—specializing in wind, solar, bio-fuels, geothermal, uranium/nuclear, hydro, clean technology and energy conservation—will also present investment opportunities at the Forum’s “Rising Star Panels”. According to Michelle Ashby, CEO of MINE LLC, which hosts the Forum, over $265 Billion will be invested in the modern energy sector by 2015 in the United State alone.
The Consulate General of Canada in Denver will host Canadian entrepreneurs from three top-tier start-up companies, who will pitch their potentially “game-changing” core business concepts during the Forum’s “Rising Star Panels” on Wednesday, Sept. 14, from 2:30 p.m. to 3:30 p.m., and on Thursday, Sept. 15, from 10:30 a.m. to 11:30 a.m. In addition, Consulate trade specialists will help position Colorado as an ideal destination for Canadian firms to headquarter their U.S. operations, feature Canada’s capabilities in the renewable energy and clean-tech sectors, and facilitate partnering opportunities between Canadian and Colorado companies.
Canada’s “Rising Star Panel” Participants:
• Enovex (www.enovexcorp.com): Located in Port City, New Brunswick, Enovex is a start-up company that researches innovative applications and develops cost-effective and highly efficient systems for carbon capture, in order to help organizations reduce their environmental impact. For example, instead of storing carbon underground—a common but controversial tactic—Enovex is looking for other uses for the carbon, nitrogen and water it would sequester from coal power plants such as feeding the carbon to algae to create bio-fuel. Enovex also provides consulting services to help business leaders understand where they could improve on each aspect of the organization—and its impacts on people, profits and the planet—in order to develop a more sustainable business plan, allowing for more environmental accountability, more scalability and less performance issues. Scott Walton, President of Enovex, will participate on “Rising Star Panel I: Up & Coming Companies”, on Wednesday, Sept. 14, 2:30 p.m. to 3:30 p.m., at The Ritz Carlton, Denver.
• Green Power Labs Inc. (www.greenpowerlabs.com): Advanced solar power forecasting solutions are required to address the variability of solar power generation. Located in Dartmouth, Nova Scotia, Green Power Labs’ SolarSatData™ is a state-of-the-art solar power forecasting technology and service for utility-scale and distributed solar PV generation facilities. SolarSatData™ provides customers with new incremental annual operational cost savings between $1.6 million and $2.6 million per 100 megawatts of installed solar PV. Dr. Alexandre Pavlovski, P.Eng., President & CEO, Green Power Labs Inc., will participate on “Rising Star Panel I: Up & Coming Companies”, on Wednesday, Sept. 14, 2:30 p.m. to 3:30 p.m., at The Ritz Carlton, Denver.
• BioDiesel Reactor (BDR) Technologies Inc. (www.bdrtechnologies.com): Located in Ottawa, Ontario, BDR’s propriety membrane reactor system produces high quality biodiesel that surpasses industry quality specifications and provides significant capital, operating and input cost savings to our customers. More specifically, this technology provides biodiesel producers with: a cost-effective solution to address the fuel filter plugging quality issues of biodiesel-diesel blends; improved processing margins; and flexibility to reduce input costs by utilizing low cost-FFA (free fatty acid) waste oils and next generation feedstocks (e.g. algae) without costly pre-treatment for FFAs or distillation of the final product. BDR’s technology can be used to retrofit existing, uneconomical and feedstock constrained production facilities as well as for new builds. Ken Lawless, President & CEO at BDR Technologies, will participate on “Rising Star Panel II: Up & Coming Companies”, on Thursday, Sept. 15, 10:30 a.m. to 11:30 a.m., at The Ritz Carlton, Denver.
In addition, several Canadian experts in the renewable energy and clean-tech sectors will be participating at the Forum as guest speakers. These key experts include:
• Milfred Hammerbacher, President; Canadian Solar Solutions Inc
• Janice Larson, Director; Renewable Energy Department, BC Ministry of Energy and Mines
• Robert Peterman, Toronto Stock Exchange & TSX Venture Exchange; Head, Business Development – Technology
• Representative from Finavera Wind Energy
“As the number one energy provider and partner to the United States, Canada is committed to growing its renewable portfolio and making its energy production cleaner by increasing energy efficiency, expanding renewable energy production and reducing environmental impacts from conventional sources,” said Ladan Amirazizi, Acting Consul General of Canada at the Consulate in Denver. “In fact, with 8,500 firms which employ more than a quarter of a million people and generate nearly $2 billion in exports annually, our clean-tech sector is currently one of the main drivers of Canada’s overall economy. Canadian companies in the renewable energy sector are continuing to research and develop innovative and clean technologies poised to help North America meet its growing energy demands.”
Furthermore, Amirazizi explains that the Government of Canada has introduced a number of initiatives, including $1.5 billion invested to increase Canada’s energy supplies from renewable sources such as solar, tidal, hydro, wind, biomass and geothermal power, and roughly three-fourths of Canada’s electricity generation is non-GHG emitting.
Attendees at the Modern Energy Investors Forum who want to participate in this international partnering opportunity should contact Guillaume Parent, Trade Commissioner for the Consulate General of Canada in Denver, at (303) 718-4774 (mobile) or guillaume.parent@international.gc.ca. For more information about Canada’s capacity in each of these renewable energy sources, or for more information about the Government of Canada’s representation in the four-state Rocky Mountain region of Colorado, Montana, Utah and Wyoming, visit the website at www.denver.gc.ca. For press inquiries regarding the Consulate General of Canada in Denver, contact Jennifer Cook, Communications Officer, at (303) 626-0672 or at jennifer.cook@international.gc.ca.
###
1625 Broadway, Suite 2600 Denver, Colorado 80202 303.626.0640
Spartan RX Gets CE Mark for UOHI test
Spartan Bioscience Announces CE Marking for First Point-of-Care DNA Personalized Medicine Testing System
The CE Mark allows the Spartan RX CYP2C19 to be distributed in select countries across Europe, Middle East, Africa, Latin America, and Asia Pacific. The Spartan RX CYP2C19 designed to help cardiologists determine most effective anti-blood clotting drug and dosage at the onset of heart attacks.
Launched in August 2010, Spartan RX CYP2C19, was designed to help cardiologists identify patients who have a gene mutation that causes impaired metabolism to the popular anti-blood clotting medication Plavix® (clopidogrel), which may lead to major adverse cardiac events. The CYP2C19*2 mutation is found in up to 30% of the population. Individuals with this mutation who receive the standard dose of Plavix following a cardiac stent insertion to open clogged arteries have an 11.7% absolute risk of death, stroke, or heart attack in the first year (compared to 8.3% for non-carriers).
The U.S. Food and Drug Administration issued a warning for Plavix in March 2010. The genotype results provided by the Spartan RX CYP2C19 test will help determine the most effective anti-blood clotting drug and dosage at the onset of heart attacks.
“Currently, genetic testing for Plavix non-response is performed in central labs and it takes one to seven days to get a test result back. This is often too late because most of the complications for CYP2C19*2 carriers occur in the first 24 to 48 hours,” said Derek So, M.D., staff cardiologist, University of Ottawa Heart Institute. “As a one-hour point-of-care test, the Spartan RX CYP2C19 has the potential to significantly reduce major cardiac events in heart attack patients.”
“The long-term trend for DNA testing is to move from the central lab to point-of-care,” said Paul Lem, M.D., founder of Spartan Bioscience. “Spartan has turned this prediction into reality by creating a fully integrated DNA collection, extraction and analysis platform, and adding an intuitive interface that can be operated by nurses and other non-technical users.”
The Spartan RX System and Spartan RX CYP2C19 test are currently available for investigational testing. At the University of Ottawa Heart Institute, Dr. So is using the testing system to run the RAPID GENE study, a prospective randomized clinical trial, which will determine if alternative anti-blood clotting therapy with Effient® (prasugrel) for CYP2C19*2 carriers reduces major adverse cardiovascular events.
In October 2010, Spartan Bioscience was named as one of Canada’s Top 10™
For more information on this announcement see:
http://eon.businesswire.com/news/eon/20101220005316/en/CYP2C19/CE-Mark/Point-of-Care
uOttawa Spin-off company (BDR Technologies) named a Top Innovator by youngStartup Ventures
BDR Technologies Named a Top Innovator -Award Recognizes Cutting Edge Private Companies Driving the Future of Innovation
BIODIESEL REACTOR (BDR) TECHNOLOGIES announced today that it has been selected to present as one of 70 Top Innovators at the annual New England Venture Summit by youngStartup Ventures. The list of privately held companies recognizes those that play a leading role in innovation for the Technology, Life Sciences and Clean-tech sectors.
As one of the Top Innovators chosen, Ken Lawless, CEO of BDR Technologies, will present the company at the exclusive 2010 New England Venture Summit on December 15th at the Hilton Boston Dedham, where a select group of over 400 entrepreneurs, investors, and corporate developers will gather to be the first to meet this next wave of leading edge companies. For more information on the summit see: http://www.youngstartup.com/newengland2010/overview.php
BDR Technologies Inc. is an Ottawa-based clean energy company that provides innovative process solutions for the global biodiesel industry. BDR’s novel membrane reactor generates high quality biodiesel, exceeding industry standards (and the more stringent standards demanded by big oil), at significantly reduced capital and operating costs, without the need for costly downstream distillation of the final product. The technology was developed at the University of Ottawa and has been licensed exclusively to BDR. A four million litre per year demonstration plant is in development and is projected to be commissioned in late 2011.
Jennerex Completes Private Placement
San Francisco, California, August 19, 2010 – Jennerex, Inc., a clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class, breakthrough targeted oncolytic products for cancer, today announced the closing of a fully subscribed private placement financing with aggregate gross proceeds of approximately $8.6 million. Proceeds from this transaction will be used to advance the Company’s oncology product platform, led by JX-594, a novel oncolytic agent that has demonstrated promising antitumor activity in Phase 1 and Phase 2 clinical trials. (more…)
OTTN at Discovery 2010
The Ottawa Technology Transfer Network attended Discovery 2010 in Toronto on May 17-18. The conference showcased ideas, innovations and solutions that are shaping Ontario’s future. Once again, OTTN showcased some of its spin off technologies – Therapeutic Monitoring Systems and IWatchLife (acquired OTTN spin off Visual Cortek). Congratulations to University of Ottawa Students Georges El-Hage, Yue Yang and Alexandru Stefanescu who won the best university energy conservation project for their Smart and Efficient Wind Turbine System.
Visit ocediscovery.com>
Visit iwatchlife.org>
Visit therapeuticmonitoring.com>
eSight: startup to watch in 2010
eSight Corporation, one of OTTN’s spin-off companies, was featured in the Ottawa Business Journal as one of Ottawa’s cream of the crop new startups to keep an eye on in 2010. The company’s lead product is a lightweight, sunglasses-like device with built-in video camera and display screens. eSight chairman Dan Mathers says the product, which is currently undergoing patient trials with an anticipated commerical debut in fall 2010, gives (more…)
Jennerex Appoints Hoyoung Huh to its Board of directors
Aujourd’hui, Jennerex Inc., une compagnie stage-clinique biothérapeutique, a annoncé la nomination de Hoyoung Huh, M.D., Ph.D. à son conseil d’administration.
Jennerex Inc., a clinical-stage cancer biotherapeutics company, today announced the appointment of Hoyoung Huh, M.D., Ph.D. to its board of directors. Dr. Huh is currently chairman of BiPar Sciences, Inc., an independent wholly-owned subsidiary of sanofi-aventis, and chairman of Epizyme, Inc., representing two leading novel cancer therapeutics companies.
eSight Announces $750,000 Investment from First Leaside Visions II Limited Partnership
eSight Corporation, un développeur d’artifices de vision électroniques innovateurs et une compagnie dérivée de RTTO, a récemment annoncé la réception d’un investissement de 750,000$ de la part de First Leaside Visions II Limited Partnership.
eSight Corporation, a developer of innovative wearable electronic vision devices for the visually impaired and one of OTTN’s spin-off companies, announced today that it has received a $750,000 investment from First Leaside Visions II Limited Partnership.
Jennerex and Lee’s Pharmaceuticals Announce Partnership for JX-594 in China
Jennerex Inc., a clinical-stage biotherapeutics company developing a proprietary breakthrough class of targeted oncolytic virus therapeutics, today announced in conjunction with Lee’s Pharmaceutical Holdings, the execution of a collaboration and license agreement for Jennerex’s lead product candidate, JX-594 (liver cancer treatment), in certain Asian territories. Lee’s is a fully integrated pharmaceutical group with operations in People’s Republic of China (PRC), Hong Kong and Macau.
Incogna launched Shopachu
Incogna, une entreprise démarrée par Kris Woodbeck, un ancien d’uOttawa, et dérivée de RTTO a récemment lancé Shopachu, un nouveau type de site Internet commerçant!! Shopachu et les algorithmes de vision assistée par ordinateur développés par Incogna viennent d’être mis en vedette par Nvidia.
Incogna, a web-based visual search engine company and one of OTTN’s spin-off companies, recently launched Shopachu, a new breed of visual shopping websites!! Shopachu and Incogna’s computer-vision algorithms have been featured by Nvidia.
Read more about it on NVIDIA INTERSECT blog >
Try Shopachu >
Learn more on Incogna >
